NCT07528248 Comparative Effects of Global Postural Re-education and NASM-based Corrective Exercises in Patients With Upper Cross Syndrome (UCS)
| NCT ID | NCT07528248 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rehana Hayat |
| Condition | Upper Cross Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2026-03-05 |
| Primary Completion | 2026-05-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2026-03-05 with a primary completion date of 2026-05-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn the comparative effects of Global postural re-education (GPR) and National Academy of Sports Medicine (NASM) based corrective exercises in participants with upper cross syndrome (UCS). The main questions it aims to answer: * Is there any difference between the effects of GPR and NASM-based corrective exercises in decreasing pain and disability and improving endurance in participants with upper cross syndrome? * Is there any difference between the effects of GPR and NASM-based corrective exercises in improving cranio-vertebral angle of participants with upper cross syndrome? Researchers will compare GPR and NASM-based corrective exercises to see if there is difference between the two treatments in decreasing pain, disability and improving endurance and cranio-vertebral angle. Participants will be: * Given treatment 3 times a week for 8 weeks. * Assessed before first treatment session (baseline), at 4th week of intervention and at the end of last treatment session (8th week).
Eligibility Criteria
Inclusion Criteria: 1. Age between 20-45 years 2. Pain in the upper back and neck region. 3. Both male and female patients 4. Rounded shoulders 5. Craniovertebral angle less than 47 degrees 6. Willingness to participate Exclusion Criteria: 1. History of spinal surgery 2. Neurological deficits (radiculopathy, myelopathy, disc herniation) 3. Severe scoliosis or structural deformity 4. Active cervical spine pathology (spondylosis, stenosis and fracture)
Frequently Asked Questions
Who can join the NCT07528248 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 45 Years, studying Upper Cross Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07528248 currently recruiting?
Yes, NCT07528248 is actively recruiting participants. Visit ClinicalTrials.gov or contact Rehana Hayat to inquire about joining.
Where is the NCT07528248 trial being conducted?
This trial is being conducted at Okāra, Pakistan.
Who is sponsoring the NCT07528248 clinical trial?
NCT07528248 is sponsored by Rehana Hayat. The trial plans to enroll 46 participants.